Description

Meracaptaz 50 mg contains Melphalan, an alkylating anticancer medicine used in the treatment of certain blood cancers and other selected malignancies. It works by damaging the DNA of rapidly dividing cancer cells, helping to slow or stop their growth. Melphalan tablets are prescribed only under the supervision of an experienced oncologist due to the risk of severe bone marrow suppression and the need for close monitoring. Key Benefits Helps treat specific cancers by inhibiting cancer cell growth. Oral tablet for convenient administration when prescribed. Commonly used in established chemotherapy protocols. May be used alone or in combination with other anticancer medicines. Treatment is individualized based on the patient's condition and response. Indications Meracaptaz (Melphalan Tablets) may be prescribed for: Multiple myeloma Ovarian cancer Other oncology indications as determined by the treating oncologist and local treatment guidelines. How It Works Melphalan belongs to the alkylating agent class of chemotherapy medicines. It forms cross-links with DNA, preventing cancer cells from replicating and dividing, which ultimately leads to cancer cell death. Dosage & Administration Take only as prescribed by your oncologist. Swallow the tablet whole with water. The dose depends on the type of cancer, body condition, and blood test results. Regular blood tests are essential during treatment to monitor blood cell counts and organ function. Do not change or stop the medication without medical advice. Possible Side Effects Common side effects may include: Low white blood cell count (neutropenia) Low platelet count (thrombocytopenia) Anemia Nausea and vomiting Loss of appetite Mouth sores Fatigue Increased risk of infections Seek immediate medical attention if you develop fever, unusual bleeding, severe bruising, persistent vomiting, or signs of a serious infection.